Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

David Douglass

Concepts (70)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma
2
2025
70
1.050
Why?
Fibromatosis, Aggressive
1
2022
3
0.790
Why?
Adenomatous Polyposis Coli
1
2022
6
0.790
Why?
Rhabdomyosarcoma, Alveolar
1
2021
8
0.740
Why?
Li-Fraumeni Syndrome
1
2021
12
0.740
Why?
Receptors, Tumor Necrosis Factor, Member 14
1
2020
5
0.680
Why?
Proto-Oncogene Proteins c-ets
1
2020
8
0.680
Why?
Sarcoma, Ewing
1
2020
28
0.660
Why?
Tumor Suppressor Protein p53
1
2021
224
0.640
Why?
Mutation
2
2022
1344
0.610
Why?
Antineoplastic Agents
2
2025
1221
0.560
Why?
DNA-Binding Proteins
1
2020
426
0.550
Why?
Transcription Factors
1
2020
566
0.520
Why?
Soft Tissue Neoplasms
2
2025
55
0.440
Why?
Breast Neoplasms
1
2021
1205
0.390
Why?
Prognosis
3
2024
2118
0.310
Why?
Adolescent
3
2024
6737
0.260
Why?
Ifosfamide
1
2024
9
0.220
Why?
Child, Preschool
2
2024
4062
0.220
Why?
Neoplasm Grading
1
2024
126
0.220
Why?
Osteoblastoma
1
2023
2
0.210
Why?
Osteoma, Osteoid
1
2023
4
0.210
Why?
Neuroblastoma
1
2023
51
0.210
Why?
Protein Kinase Inhibitors
1
2025
228
0.200
Why?
Genes, APC
1
2022
4
0.200
Why?
Child
3
2025
7229
0.200
Why?
Doxorubicin
1
2024
241
0.200
Why?
Combined Modality Therapy
1
2024
639
0.190
Why?
Survival Rate
1
2024
952
0.180
Why?
Bone Neoplasms
1
2023
184
0.180
Why?
Proto-Oncogene Protein c-fli-1
1
2020
8
0.170
Why?
RNA-Binding Protein EWS
1
2020
13
0.170
Why?
Ultrasonography, Doppler, Color
1
2020
33
0.170
Why?
Cyclin D1
1
2020
57
0.170
Why?
Chemotherapy, Adjuvant
1
2020
124
0.160
Why?
Neoplasm Recurrence, Local
1
2024
643
0.160
Why?
DNA Copy Number Variations
1
2020
117
0.160
Why?
Humans
8
2025
52593
0.160
Why?
Carboxymethylcellulose Sodium
1
2018
2
0.150
Why?
Incidence
1
2022
1077
0.150
Why?
Glycerol
1
2018
19
0.150
Why?
Dry Eye Syndromes
1
2018
11
0.150
Why?
Follow-Up Studies
1
2024
2291
0.150
Why?
Gene Expression Profiling
1
2023
1110
0.140
Why?
Female
4
2024
28262
0.140
Why?
Prospective Studies
1
2024
2457
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
1031
0.140
Why?
Immunohistochemistry
1
2020
984
0.140
Why?
Infant
1
2024
3720
0.120
Why?
Skin Neoplasms
1
2020
500
0.120
Why?
Young Adult
1
2024
4337
0.110
Why?
Magnetic Resonance Imaging
1
2020
1545
0.100
Why?
Treatment Outcome
2
2020
5486
0.100
Why?
Retrospective Studies
1
2024
6671
0.090
Why?
Adult
2
2024
14170
0.080
Why?
Male
2
2024
26863
0.060
Why?
Heterogeneous-Nuclear Ribonucleoproteins
1
2023
2
0.050
Why?
Polypyrimidine Tract-Binding Protein
1
2023
11
0.050
Why?
Proto-Oncogene Proteins c-fos
1
2023
60
0.050
Why?
Transcriptome
1
2023
368
0.040
Why?
Diagnosis, Differential
1
2023
1048
0.040
Why?
Administration, Ophthalmic
1
2018
2
0.040
Why?
Viscosity
1
2018
8
0.040
Why?
Tears
1
2018
11
0.040
Why?
Ophthalmic Solutions
1
2018
20
0.040
Why?
Drug Combinations
1
2018
134
0.040
Why?
Double-Blind Method
1
2018
718
0.030
Why?
Infant, Newborn
1
2023
2891
0.030
Why?
Aged
1
2018
10191
0.010
Why?
Middle Aged
1
2018
13096
0.010
Why?
Douglass's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description